In a concise leadership update, Lasa Supergenerics Limited disclosed that Ganesh Suresh Potdar has tendered his resignation from the post of Additional Director in the capacity of Whole-Time Director, with effect from the close of business on Tuesday, 25 August 2026. The resignation letter notes no other material reasons beyond those detailed in the letter dated 25 August 2026.
Potdar’s exit removes a key executive from the company’s boardroom, signaling a shift in LASA’s operating leadership. The notice does not indicate a successor, leaving the board to navigate the interim period as it continues its strategic course.
The company said the information would be made available on its website and referenced the resignation letter that was furnished to the board and the stock exchanges. Potdar also requested an acknowledgment of receipt and a copy of the DIR-12 E-form filed with the Registrar of Companies.
With the generics specialist aiming to maintain momentum in a competitive market, observers will watch how LASA manages the transition and preserves continuity in its executive leadership.